(Press-News.org) Study’s findings point to the importance of considering other risk factors beyond breast density.
Dense breast tissue, which contains a higher proportion of fibrous tissue than fat, is a risk factor for breast cancer and also makes it more difficult to identify cancer on a mammogram. Many states have enacted laws that require women with dense breasts to be notified after a mammogram, so that they can choose to undergo supplemental ultrasound screening to improve cancer detection. A recent study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, evaluated the results of such additional screening to determine its benefits and harms to patients.
Although supplemental ultrasound screening may detect breast cancers missed by mammography, it requires additional imaging and may lead to unnecessary breast biopsies among women who do not have breast cancer. Therefore, it is important to use supplemental ultrasound only in women at high risk of mammography screening failure—in other words, women who develop breast cancer after a mammogram shows no signs of malignancy.
Brian Sprague, PhD, of the University of Vermont Cancer Center, and his colleagues evaluated 38,166 supplemental ultrasounds and 825,360 screening mammograms without supplemental ultrasounds during 2014–2020 at 32 U.S. imaging facilities within three regional registries of the Breast Cancer Surveillance Consortium.
The team found that 95.3% of supplemental ultrasounds were performed in women with dense breasts. In comparison, 41.8% of mammograms without additional screening were performed in women with dense breasts.
Among women with dense breasts, a high risk of interval invasive breast cancer was present in 23.7% of women who underwent ultrasounds, compared with 18.5% of women who had mammograms without additional imaging.
The findings indicate that ultrasound screening was highly targeted to women with dense breasts, but only a modest proportion of these women were at high risk of mammography screening failure. A similar proportion of women who received only mammograms were at high risk of mammography screening failure.
“Among women with dense breasts, there was very little targeting of ultrasound screening to women who were at the highest risk of a mammography screening failure. Rather, women with dense breasts undergoing ultrasound screening had similar risk profiles to women undergoing mammography screening alone,” said Dr. Sprague. “In other words, many women at low risk of breast cancer despite having dense breasts underwent ultrasound screening, while many other women at high risk of breast cancer underwent mammography alone with no supplemental screening.”
Clinicians can consider other breast cancer risk factors beyond breast density to identify women who may be appropriate for supplemental ultrasound screening. Publicly available risk calculators from the Breast Cancer Surveillance Consortium are available that also consider age, family history, and other factors (https://www.bcsc-research.org/tools).
Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the CANCER Newsroom upon online publication. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com
Full Citation:
“Breast cancer risk characteristics of women undergoing whole breast ultrasound screening versus mammography alone.” Brian L. Sprague, Laura Ichikawa, Joanna Eavey, Kathryn P. Lowry, Garth Rauscher, Ellen S. O’Meara, Diana L. Miglioretti, Shuai Chen, Janie M. Lee, Natasha K. Stout, Jeanne S. Mandelblatt, Nila Alsheik, Sally D. Herschorn, Hannah Perry, Donald L. Weaver, and Karla Kerlikowske. CANCER; Published Online: June 12, 2023 (DOI: 10.1002/cncr.34768).
URL Upon Publication: http://doi.wiley.com/10.1002/cncr.34768
Author Contact: Kate Strotmeyer, at katherine.strotmeyer@med.uvm.edu
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow us on Twitter @JournalCancer.
About Wiley
Wiley is one of the world’s largest publishers and a global leader in scientific research and career-connected education. Founded in 1807, Wiley enables discovery, powers education, and shapes workforces. Through its industry-leading content, digital platforms, and knowledge networks, the company delivers on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, Twitter, LinkedIn and Instagram.
END
Which women should receive more than mammograms to screen for breast cancer?
2023-06-12
ELSE PRESS RELEASES FROM THIS DATE:
Twenty species of sea lettuce found along the Baltic and Scandinavian coasts
2023-06-12
The number of species of the green alga sea lettuce in the Baltic Sea region and Skagerak and is much larger than what was previously known. Researchers at the University of Gothenburg have surveyed 10,000 kilometres of coast and found twenty species of sea lettuce.
Green macroalgae of the genus Ulva, also known as sea lettuce, are almost ubiquitous in the wider Baltic Sea region and and can be found from the Atlantic waters all the way up to the Bay of Bothnia in the Baltic Sea. Sea lettuce reproduce easily and grow ...
Cancer diagnoses dropped sharply in Alberta during COVID-19 response
2023-06-12
Pandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well as melanoma, according to a new Alberta study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221512.
"The sweeping and unprecedented measures enacted at the beginning of the COVID-19 pandemic in Alberta had an inevitable impact on cancer care," writes Dr. Darren Brenner, an epidemiologist in Calgary, Alberta, and associate professor at the University of Calgary's Cumming School of Medicine, with coauthors. "Even though treatment and urgent surgeries for cancers were prioritized ...
Canada’s carbon pricing poses a $256 billion financial risk for borrowers and banks
2023-06-12
By putting a price on the cost of carbon, the Government of Canada aims to curtail greenhouse gas (GHG) emissions, but it comes with an increased risk for financial lenders and borrowers with high carbon emissions.
In a first-of-its-kind study, University of Waterloo researchers analyzed the effects of Canada’s carbon price regime on the economy. The results indicate that as carbon costs rise, high-emitting carbon industries such as mining and energy are at the greatest risk of default, with total assets of $256 billion at risk of being lost and almost a quarter ...
NYU Abu Dhabi researchers uncover new insights into why individuals are affected differently by COVID-19 infection
2023-06-12
Abu Dhabi, UAE (June 12): A team of researchers at NYU Abu Dhabi, led by Associate Professor of Biology Youssef Idaghdour and working in collaboration with clinicians at several Abu Dhabi hospitals, investigated the association between microRNAs, a class of small RNA molecules that regulate genes, and COVID-19 severity among 259 unvaccinated COVID-19 patients living in Abu Dhabi. The team identified microRNAs that are associated with a weakened immune response and admission to ICU.
During this process, ...
Vaccine against deadly chytrid fungus primes frog microbiome for future exposure
2023-06-12
UNIVERSITY PARK, Pa. — A human or animal’s microbiome — the collection of often beneficial microorganisms, including as bacteria and fungi, that live on or within a host organism — can play an important role in the host’s overall immune response, but it is unclear how vaccines against harmful pathogens impact the microbiome. A new study led by researchers at Penn State found that a new vaccine against the deadly chytrid fungus in frogs can shift the composition of the microbiome, making frogs more resilient to future exposure to the ...
Should robots be given a human conscience?
2023-06-12
Modern-day society relies intrinsically on automated systems and artificial intelligence. It is embedded into our daily routines and shows no signs of slowing, in fact use of robotic and automated assistance is ever-increasing.
Such pervasive use of AI presents technologists and developers with two ethical dilemmas – how do we build robots that behave in line with our values and how to we stop them going rogue?
One author suggests that one option which is not explored enough is to code more humanity into robots, gifting robots with traits such as empathy and compassion.
Is ...
Research brings hope for early treatment of brain degeneration in ‘children of the night’
2023-06-12
Glasgow, UK: Xeroderma pigmentosum (XP) is a rare and devastating genetic disorder characterised by an inability to repair skin damage caused by ultraviolet (UV) light. As a result, patients with XP develop skin cancers, usually in childhood. Once diagnosed, they can be protected by avoiding sunlight (hence sometimes being called ‘children of the night’), wearing special clothing and sunglasses, and using sunscreen. But some will also develop neurodegenerative conditions such as hearing loss, loss of intellectual function, poor co-ordination and seizures. Finding out why this is, and which ...
Polygenic risk scores could improve colorectal cancer screening
2023-06-12
Glasgow, UK: Rates of colorectal cancer are high despite widespread adoption of screening programmes in many high-income European countries. Such programmes tend to use a one-size-fits-all approach where most people are screened starting from the same age, and no individual factors are considered in organised population screening. Now, based on one of the largest genomics studies on the topic to date, researchers from Finland have outlined how common genetic factors could be used to identify individuals at high risk of developing the disease and hence improve current colorectal screening strategies.
Max Tamlander, MD at the Institute ...
Results from first randomised controlled trial of genetic counselling for familial and inherited colorectal cancer show significant improvements in patient empowerment
2023-06-11
Glasgow, UK: Genetic counselling is essential when dealing with individuals who are affected by, or at risk of, inherited disease. Although it is known to be useful in helping patients cope with test results and deal with uncertainty, there have been very few randomised controlled trials (RCTs) of its effectiveness. Dr Andrada Ciuca, a post-doctoral researcher at Babes-Bolyai University, Cluj-Napoca, Romania, will tell the annual conference today (Sunday 11 June) that the results of the first RCT of genetic counselling in familial colorectal cancer (fCRC) show that it provided significant ...
Blood biomarkers plus genomics predict common disease risk more accurately than genomic information alone
2023-06-10
Glasgow, UK: Being to identify people at high risk of chronic disease means that they can be targeted with prevention measures before they become sick. Polygenic risk scores, where genomic information alone is used to assess the risk of developing diseases, have been receiving a lot of attention recently, but research to be presented at the annual conference of the European Society of Human Genetics today (Saturday 10 June) suggests that combining blood biomarkers with genomic information gives more accurate, cost-effective results.
Dr Jeffrey Barrett, Chief Scientific Officer, Nightingale Health, Helsinki, ...